Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
07.02.24
/
50%
€289.60
Target price
07.02.25
€324.87
Performance (%)
-1.74%
End price
08.02.25
€284.55
Summary
This prediction ended on 08.02.25 with a price of €284.55. With a performance of -1.74%, the BUY prediction for Amgen Inc. by The_Goldman_Sachs_Gr closed slightly in the red. The_Goldman_Sachs_Gr has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.32 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 2.692% | 2.692% | 22.658% |
| iShares Core DAX® | -0.471% | 0.925% | 3.017% |
| iShares Nasdaq 100 | 4.192% | 15.863% | 33.321% |
| iShares Nikkei 225® | -0.073% | 8.098% | 47.961% |
| iShares S&P 500 | 2.680% | 8.747% | 22.969% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $313.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten